Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Promising interim results from ALS study testing IPL344

europeanpharmaceuticalreviewSeptember 16, 2020

Tag: IPL344 , ALS , ALSFRS-R

PharmaSources Customer Service